Orizuru Therapeutics, Inc. jobs and careers

Japan

About Orizuru Therapeutics, Inc.

This company is a spinout from Takeda Pharmaceuticals and Kyoto University, focusing on the development of induced pluripotent stem cell (iPSC) technology-based regenerative medicine.

Biotechnology Pharmaceutical

Founded: 2021
Employees: 11 to 50
Headquarters: Japan

Leadership

The top of Orizuru Therapeutics, Inc.'s org chart, with how many people report into each leader.

Kenji Nonaka

Chief Executive Officer

Jobs at Orizuru Therapeutics, Inc.

No open positions right now. Explore more companies on TheJobsMap.